BioMarin Pharmaceutical Inc. (BVMF:B1MR34)

BioMarin Pharmaceutical Statistics

Total Valuation

BVMF:B1MR34 has a market cap or net worth of BRL 56.28 billion. The enterprise value is 51.66 billion.

Market Cap	56.28B
Enterprise Value	51.66B

Important Dates

The next estimated earnings date is Friday, February 20, 2026.

Earnings Date	Feb 20, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+2.10%
Shares Change (QoQ)	-2.57%
Owned by Insiders (%)	0.78%
Owned by Institutions (%)	91.55%
Float	178.16M

Valuation Ratios

The trailing PE ratio is 20.29 and the forward PE ratio is 11.53.

PE Ratio	20.29
Forward PE	11.53
PS Ratio	3.41
PB Ratio	1.74
P/TBV Ratio	1.88
P/FCF Ratio	12.69
P/OCF Ratio	11.55
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.07, with an EV/FCF ratio of 11.65.

EV / Earnings	18.62
EV / Sales	3.15
EV / EBITDA	12.07
EV / EBIT	13.71
EV / FCF	11.65

Financial Position

The company has a current ratio of 4.83, with a Debt / Equity ratio of 0.10.

Current Ratio	4.83
Quick Ratio	2.84
Debt / Equity	0.10
Debt / EBITDA	0.75
Debt / FCF	0.73
Interest Coverage	66.49

Financial Efficiency

Return on equity (ROE) is 9.07% and return on invested capital (ROIC) is 7.01%.

Return on Equity (ROE)	9.07%
Return on Assets (ROA)	6.15%
Return on Invested Capital (ROIC)	7.01%
Return on Capital Employed (ROCE)	10.44%
Revenue Per Employee	5.42M
Profits Per Employee	912,339
Employee Count	3,040
Asset Turnover	0.43
Inventory Turnover	0.45

Taxes

In the past 12 months, BVMF:B1MR34 has paid 846.60 million in taxes.

Income Tax	846.60M
Effective Tax Rate	23.39%

Stock Price Statistics

The stock price has decreased by -28.27% in the last 52 weeks. The beta is 0.30, so BVMF:B1MR34's price volatility has been lower than the market average.

Beta (5Y)	0.30
52-Week Price Change	-28.27%
50-Day Moving Average	156.31
200-Day Moving Average	207.66
Relative Strength Index (RSI)	35.19
Average Volume (20 Days)	80

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.33

Income Statement

In the last 12 months, BVMF:B1MR34 had revenue of BRL 16.49 billion and earned 2.77 billion in profits. Earnings per share was 14.29.

Revenue	16.49B
Gross Profit	13.41B
Operating Income	3.79B
Pretax Income	3.62B
Net Income	2.77B
EBITDA	4.23B
EBIT	3.79B
Earnings Per Share (EPS)	14.29

Balance Sheet

The company has 7.88 billion in cash and 3.22 billion in debt, giving a net cash position of 4.66 billion.

Cash & Cash Equivalents	7.88B
Total Debt	3.22B
Net Cash	4.66B
Net Cash Per Share	n/a
Equity (Book Value)	32.28B
Book Value Per Share	168.03
Working Capital	16.29B

Cash Flow

In the last 12 months, operating cash flow was 4.87 billion and capital expenditures -436.19 million, giving a free cash flow of 4.43 billion.

Operating Cash Flow	4.87B
Capital Expenditures	-436.19M
Free Cash Flow	4.43B
FCF Per Share	n/a

Margins

Gross margin is 81.32%, with operating and profit margins of 22.99% and 16.82%.

Gross Margin	81.32%
Operating Margin	22.99%
Pretax Margin	21.95%
Profit Margin	16.82%
EBITDA Margin	25.66%
EBIT Margin	22.99%
FCF Margin	26.89%

Dividends & Yields

BVMF:B1MR34 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.10%
Shareholder Yield	-2.10%
Earnings Yield	4.93%
FCF Yield	7.88%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BVMF:B1MR34 has an Altman Z-Score of 5.84 and a Piotroski F-Score of 7.

Altman Z-Score	5.84
Piotroski F-Score	7